Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone

NCT00538642 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder
Bipolar Disorder

Interventions

DRUG: ziprasidone

Sponsor

The University of Texas Health Science Center at San Antonio